Spravato vs At-Home Ketamine Therapy: A Complete Comparison Guide

Understanding Your Ketamine Therapy Options: Spravato vs At-Home Treatment

If you're exploring ketamine therapy for treatment-resistant depression, you've likely encountered two main options: Spravato (esketamine nasal spray) and at-home oral ketamine therapy. While both involve ketamine, they're very different treatments with distinct advantages and limitations.

What is Spravato?

Spravato is the brand name for esketamine, a nasal spray form of ketamine that's FDA-approved specifically for treatment-resistant depression and major depressive disorder with suicidal ideation. It's administered only in certified healthcare facilities under medical supervision.

Key Features of Spravato

• FDA approval: Specifically approved for treatment-resistant depression
• Insurance coverage: More likely to be covered by insurance plans
• Clinic-based: Must be administered in a certified facility
• Supervision required: 2+ hours of monitoring after each dose
• Frequency: Twice weekly initially, then weekly or every other week

What is At-Home Oral Ketamine Therapy?

At-home ketamine therapy uses low-dose oral ketamine (troches or tablets) that dissolve under your tongue. It's prescribed by licensed clinicians and taken at home under telehealth supervision.

Key Features of At-Home Ketamine

• Off-label use: Legal and common practice, but not specifically FDA-approved for depression
• Self-pay: Typically not covered by insurance
• Home-based: Taken in the comfort and privacy of your home
• Flexible schedule: Dose on your timeline, usually 2-3 times per week
• Lower monitoring burden: Regular telehealth check-ins vs. clinic visits

Comparing Effectiveness

Both treatments have shown significant efficacy for treatment-resistant depression, though they work slightly differently:

Spravato Clinical Results

• FDA approval based on multiple clinical trials showing efficacy vs. placebo
• Rapid onset of antidepressant effects (within days to weeks)
• Sustained benefits with continued treatment
• Specifically studied in treatment-resistant depression

At-Home Ketamine Results

• Numerous studies show comparable efficacy to IV ketamine
• Similar rapid onset of benefits
• Lower doses may have fewer side effects
• Flexibility may improve treatment adherence

Cost Comparison

The financial difference between these options is significant:

Spravato Costs

• With insurance: Copays typically $10-50 per session
• Without insurance: $800+ per session
• Frequency: 2x/week initially, then weekly, then bi-weekly
• Annual cost: Varies widely based on insurance coverage

At-Home Ketamine Costs

• Monthly cost: $124-350 depending on provider
• No insurance: Almost never covered
• All-inclusive: Medication, consultation, and monitoring included
• Annual cost: $1,500-4,200

Convenience and Lifestyle Impact

Spravato Requirements

• Must visit certified clinic for each dose
• 2+ hours of supervised monitoring required
• Cannot drive for remainder of treatment day
• Rigid scheduling around clinic availability
• Time off work/other commitments for appointments

At-Home Ketamine Flexibility

• Take medication in your own home
• 30-45 minute treatment window
• Dose in evening, function normally next day
• Schedule around your life, not clinic hours
• No travel to/from appointments

Side Effects and Safety

Both treatments have similar side effect profiles, but the experience differs:

Spravato Side Effects

• Dissociation, dizziness, nausea (during 2-hour monitoring)
• Sedation (reason for extended monitoring)
• Nasal discomfort from spray delivery
• Blood pressure increases (monitored in clinic)

At-Home Ketamine Side Effects

• Mild dissociation, drowsiness (lower doses = milder effects)
• Effects typically resolve within 1-2 hours
• Less intense due to lower dosing
• Self-monitored (though provider support available)

Who Might Prefer Spravato?

• People who want FDA-approved treatment specifically
• Those with good insurance coverage for the treatment
• Patients who prefer maximum medical supervision
• People uncomfortable with self-administered treatment
• Those who need the structure of clinic-based care

Who Might Prefer At-Home Ketamine?

• People seeking maximum convenience and privacy
• Those with busy schedules that can't accommodate clinic visits
• Patients who prefer lower-dose, gentler treatment
• People comfortable with self-administration under telehealth guidance
• Those seeking more affordable treatment options

Making Your Decision

The choice between Spravato and at-home ketamine therapy depends on your specific circumstances:

• Insurance situation: If your insurance covers Spravato, cost may favor that option
• Schedule flexibility: At-home therapy offers much more convenience
• Treatment philosophy: Do you prefer maximum medical oversight or more autonomy?
• Previous experiences: Some people do better with one delivery method vs. another
• Geographic access: Spravato requires certified clinics; at-home works anywhere

The Bottom Line

Both Spravato and at-home ketamine therapy are legitimate, effective treatments for treatment-resistant depression. Spravato offers FDA approval and potential insurance coverage but requires significant time and scheduling commitments. At-home ketamine provides convenience and flexibility but is typically self-pay.

The best choice is the one you'll actually stick with long-term. Consider your lifestyle, financial situation, treatment preferences, and discuss both options with qualified healthcare providers who can help you make the decision that's right for your specific situation. Ready to take the next step? Get started with Kalm today. Explore the Kalm program.